Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)

Clinical trial NCT00076856 · COMPLETED

Trial details

NCT number: NCT00076856
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Neoplasm Metastasis Brain Neoplasms

Start date: 2004-03-31
Primary completion: 2006-03-31
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.